WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard Bryan RiggsbeeChief Financial Officer2023-03-0215,000$22.55
$338.25kSell
Nicole LambertChief Operating Officer2023-03-0213,184$22.74
$299.82kSell
Margaret AnconaSVP Chief of Staff2023-02-252,556$18.54
$47.39kSell
Kevin Richard HaasChief Technology Officer2023-02-251,012$18.54
$18.76kSell
Richard Bryan RiggsbeeChief Financial Officer2023-02-1811,222$19.42
$217.93kSell
Richard Bryan RiggsbeeChief Financial Officer2023-01-209,400$20.04
$188.39kSell
Richard Bryan RiggsbeeChief Financial Officer2023-01-18600$20.01
$12.01kSell
Dale MuzzeyChief Scientific Officer2023-01-01302$14.51
$4.38kSell
Nicole LambertChief Operating Officer2023-01-01853$14.51
$12.38kSell
Richard Bryan RiggsbeeChief Financial Officer2022-12-2720,000$15.15
$303.00kSell

1 of 6

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc17.67%14,356,099$331.34MInstitution
Vanguard Group Inc11.46%9,311,761$214.92MInstitution
Camber Capital Management LP8.62%7,000,000$161.56MInstitution
Wellington Management Group LLP8.36%6,787,223$156.65MInstitution
State Street Corp6.18%5,020,423$115.87MInstitution
Earnest Partners LLC4.07%3,304,456$76.27MInstitution
Glenview Capital Management LLC3.81%3,097,768$71.50MInstitution
Bank Of America Corp3.26%2,649,251$61.14MInstitution
Dimensional Fund Advisors LP3.24%2,633,864$60.79MInstitution
Disciplined Growth Investors Inc2.80%2,272,444$52.45MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN92.16%7.84%Net SellingNet Selling
PACB90.94%7.17%Net SellingNet Selling
NEO70.12%29.88%Net BuyingNet Buying
RDNT58.20%41.80%Net SellingNet Selling
OLK29.16%0.00%
View Top Diagnostic & Research Stocks

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 99.28% institutional shareholders, 8.44% Myriad Genetics insiders, and 0.00% retail investors. Paul J. Diaz is the largest individual Myriad Genetics shareholder, owning 1.28M shares representing 1.58% of the company. Paul J. Diaz's Myriad Genetics shares are currently valued at $30.50M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.